Aclipse management team has extensive experience in drug development including nonclinical and clinical development, regulatory manufacturing, and drug product introductions. Our team has a strong proven track record in business development, including in- and out-licensing, acquisitions, and collaborations. Aclipse management team members recently exited Thar Pharmaceuticals (acquired by Grünenthal GmbH) and Lev Pharmaceuticals (now Takeda).